The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.
The following is a summary of “Therapeutic outcomes and safety of radiofrequency ablation for primary papillary thyroid ...
In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...
A large-scale study of low-risk thyroid cancer patients proved that the quality of life can be maintained with 'active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results